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Intravenous injection of hapten-conjugated syngeneic cells results in specific im-
munological tolerance affecting both hapten-specific contact sensitivity and plaque-
forming cell responses (1-4) . Although the underlying basis for this nonresponsiveness
is not fully understood, it appears that both the T- and B-cell compartments may be
affected (3-5) . In addition, several studies have reported the generation of specific
suppressor T cells under these conditions (4-6).
The antigen that was used to induce specific nonresponsiveness (suppression) in
these studies was the synthetic linear polypeptide of L-glutamic acid, L-lysine and L-
phenylalanine (GLO).1 This antigen was chosen for several reasons. (a) The immune
response to GL4 is under histocompatibility-linked immune response gene control (7) .
(b) Although previous attempts to identify GLO specific suppressor T cells in nonre-
sponder mice have been unsuccessful (8, 9), we questioned whether induction with
antigen-modified syngeneic cells would be a more efficient means of inducing T
suppressor cells. (c) In addition, we sought to provide evidence that nonresponder
mice could generate functional T cells with specificity for GLO.
To date, all systems that analyzed nonresponsiveness induced with antigen-modified
syngeneic cells employed small, chemically reactive molecules which were covalently
conjugated to cell surface proteins. In the present study, we have used a different
method of coupling antigen to spleen cells. This new coupling method uses the ability
of palmitoyl-derivatized polypeptides to adhere to cell membranes. Thus, polypeptides
can be coupled onto spleen cells without excessive chemical modification of the
peptide and without the formation of covalent bonds between the polypeptide
antigens and any cell surface molecules. We now demonstrate that the intravenous
administration of syngeneic spleen cells modified with a palmitoyl-derivatized poly-
peptide results in antigen-specific nonresponsiveness and the induction of specific
suppressor T cells.
* Supported by grants AI-13419 and AI-00152 from the National Institutes of Health, and by grant
PCM 75-22422 from the National Science Foundation.
' Abbreviations used in this paper: C, complement; GL, poly-(L-Gluso-L-Lys"); GLO, poly-(L-GIu'-L-Lys'-
L-Phe); FyG, fowl gamma globulin; GLO-FyG, covalent conjugate of G14 and FyG; GL-FyG, covalent
conjugate of GL and FyG; M/P, suspension of Maalox and pertussis vaccine in PBS; MEM, minimal
essential medium; NMS, normal mouse serum; PBS, phosphate-buffered saline; PFC, plaque-forming cells;
SRBC, sheep erythrocytes; p-GL¢, the palmitoyl derivative of GLrb; p-GL¢-spl cells, pGL¢-coupled spleen
cells.
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Materials and Methods
Mice.
￿
C57BL/6 male mice were purchased from The Jackson Laboratory, Bar Harbor,
Maine. All experimental animals were between 8 and 12 wk of age at the beginning of
immunization. Animals were age matched in each experiment.
Antigen.
￿
The linear terpolymers~oly-(L-Glu56-L-Lys35-L-Phe), GL4, lot GLPl, average mol
wt 38,000, and poly-(L-Glu6o-L-Lys" , GL, lot L641, average mol wt 40,000 were prepared by
Miles Yeda, Ltd., Rehovot, Israel. Fowl gamma globulin (FyG) was purchased from Miles
Laboratories, Inc., Elkhart, Ind. GL4o-FyG and GL-FyG were synthesized with the Schiff base
method (10) . The GLO-FyG or GL-FyG conjugates along with unreacted FyG were separated
from theunreacted GLO or GL with 45 or 100% saturated ammonium sulfate respectively, and
then dialyzed extensively in phosphate-buffered saline (PBS).
Immunization.
￿
Mice were immunized i.p. in a volume of0.2 ml with 20#g ofGLO conjugated
to FyG. The adjuvant was a mixture of 1% Maalox and 25% pertussis vaccine (M/P). Maalox
was purchased from William H. Rorer, .Inc., Fort Washington, Pa. and pertussis vaccine was
purchased from Eli Lilly and Co., Indianapolis, Ind.
Palmitoyl-GLO.
￿
The palmitoyl derivative of GLO (p-GLO) was synthesized by the method of
Cheung et al. (10) . Trace amountsof palmitoyl-GL
￿
1126 were used to estimate the amount of
antigen bound per cell (10) .
Induction of Suppression.
￿
Twice-washed single spleen cell suspensions were pelleted and
resuspended in 1 mg/ml p-GLO in PBS. 2 F,1 of the p-GLO solution was used for every 106
spleen cells. Control cells were incubated in PBS instead of p-GLO. After incubation at 37°C
for 30 min, the cells were twice washed in minimal essential medium (MEM) containing 0.3%
heparin. After they were washed, the cells were resuspended to 6 X 107 cells/ml, and 0.5-m1
quantities were injected per mouse, i.v.
Adoptive Transfer.
￿
5 days after being primed with p-GL0-coupled spleen cells, mice were
sacrificed, the recipient spleens were teased in sterile MEM with 0.3% heparin, and the cells
were washed twice and resuspended in heparinized MEM for i.v. injection into normal
recipients. These recipient mice were then immediately challenged with 20 ug GLO-FyG in
Maalox and pertussisadjuvant i.p., and the GL0 and FyG-specific spleen plaque-forming cells
(PFC) assayed 8 days afterwards.
Anti-Thy-I Treatment.
￿
10s suppressor spleen cells from p-GLO-cell primed mice were pelleted
and incubated with 0.5 ml of a 1:2 dilution of AKR anti-C3H thymocyte serum or normal
mouse serum as control. After 30 min at 20°C the serum was removed and 0.5 ml rabbit
complement diluted 1:5 was added in L-15 medium with 1% DNase for a 30-min incubation
at 37°C and the cells were resuspended in the same media for i .v. injection.
Cyclophosphamide Treatment.
￿
Cyclophosphamide (Cytoxan) was purchased from Mead John-
son &Co., Evansville, Ind.The drug was administered intraperitoneally in thedose of5 mg/kg.
2 days after cytoxan treatment, 3 X 107 p-GL0-coupled spleen cells (p-GL0-spl cells) were
injected i.v. to induce tolerance.
PFCAssay.
￿
The antibody responsesto GLO-FyG and GL-FyG were enumerated 7 or 8 days
after immunization by a modification oftheJerne hemolytic plaque technique (10) . GLO-sheep
erythrocytes (SRBC) or GL-SRBC were prepared with respective palmitoyl conjugates (10).
FyG-SRBC were prepared by incubating a chicken anti-SRBC antiserum with washed SRBC
at 37°C for 30 min (9). Agoat anti-,u antiserumprovided by Dr. R. Asofsky, National Institutes
of Health, Bethesda, Md. wasused to inhibit IgM PFC, and a rabbit anti-mouse IgGwas used
to develop IgG PFC. Only PFC that were inhibitable with 25-50 ug per slide of free ligand
were reported as antigen-specific plaques. Generally, 95-100% PFCs arespecifically inhibitable.
All results are expressed as PFC per spleen. The cell recovery per spleen did not vary
significantly between groups.
Statistical Analysis.
￿
All data were analyzed for significance by using a two-tailed Student's
t test, performed on a Wang 700calculator (Wang Laboratories, Inc., Lowell, Mass.).
Results
G4-Specific Nonresponsiveness.
￿
When appropriate quantities of p-GL4 were injected
i.v. into C57BL/6mice, GLO-specific nonresponsiveness was induced (Table I). In theCHEUNG, SHERR, HEGHINIAN, BENACERRAF, AND DORF
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TABLE I
GLO-Specific Tolerance Induction with p-GL¢ in C57BL/6 Mice
* Arithmetic mean of PFC response t SE.
$ C57BL/6 mice were injected with 10 or 1 tag p-GLO i .v. Control mice received PBS. 3 days later they
were immunized with 20 gg GI.,O-FyG in M/P (day 0) and their spleens were assayed 8 days later (day
8) .
§ p-GLO was coupled onto spleen cells. To induce tolerance, 107 GL0-spl cells were injected into C57BL/
6 mice. Control mice received 107 normal spleen cells. 3 days later both groups were immunized with 20
ttg GL¢-FyG in M/P. On day 8 their spleens were assayed.
~~ Indicates P < 0.01 .
first experiment mice were injected with 10 or 1 [Lg of p-GL4 in PBS i.v. Three days
later, they were immunized with 20 fig GLO-FyG in M/P (day 0) . On day 8 their
spleens were assayed for GL¢-specific and FyG-specific PFC responses. When 10 Ag p-
GL4 was injected, both the IgM and IgG anti-GLO responses were significantly
reduced (Table I) ; however, there was no reduction of the FyG response (vide infra) .
In contrast, no significant tolerance was noted when 1 lag of p-GL4 was used as
pretreatment. In separate experiments 10 ng to 1 Ag doses of soluble p-GLO also failed
to affect the GL.O-specific PFC response, whereas 10-NLg doses were again tolerogenic
(data not shown) . It was likely that hydrophobic molecules such as p-GL4 reacted
with both serum proteins and cells. However, because the cell-bound antigen may be
more effective in producing nonresponsiveness, the next experiment was carried out
to elucidate the importance of cell surface-associated GL4 molecules (Table I) . Mice
were injected with 107 GL.p-coupled syngeneic spleen cells (p-GLO-spl cells) or with
107 control spleen cells. 3 days later they were immunized with 20 ltg G14-FyG in
M/P (day 0) . 8 days later their spleens were assayed for GLO PFC responses. In mice
that received p-GL.0-spl, both the IgM and IgG anti-GLcp responses were decreased
by 70-80%, compared with mice that received control cells. The efficiency of cell
surface-associated GLqS in the induction of tolerance was evident from the trace
labeling studies. The data indicated that 0. 1-Ftg quantities of GL4 were carried by the
107 p-GL.~-spl cells able to induce tolerance, whereas, as demonstrated above, 0.01-1-
g,g quantities of p-GL4 (when administered i.v. as the soluble form) were not able to
decrease the GL4 PFC response to G14-FyG (Table I) .
To demonstrate that the decrease in the GL4 PFC response on day 8 after
immunization was not the result of a shift in the appearance of the peak of the
antibody response, the PFC responses of the tolerized mice were analyzed at various
days after immunization. As shown in Fig. 1 A, day 8 after immunization was the
peak of the PFC response for both control and tolerant mice. Moreover, the immune
response of the tolerant mice remained significantly diminished throughout the period
of day 6 to day 12. This tolerance is GL4 specific, because the anti-FyG PFC response
was not affected (Fig. 1 B) . Furthermore, the PFC response to trinitrophenyl-keyhole
Experi-
ment
number
Pretreatment
Number
of mice
GLO-specific
IgM
PFC/spleen t SE*
IgG
1 PBS$ 7 8,471 t 882 8,014 t 917
10 Itg p-GLO 6 3,150 t 4951 3,200 t 65011
1 tlg p-GLo 3 6,600 1 435 8,200 ± 251
2 107 Normal spl cells§ 3 26,133 t 634 36,467 t 1,471
107 GLO-spl cells 4 7,400 t 1,77911 8,900 t 2,399111542
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(A) Kinetics ofGLO-specific PFC response in control (-) and tolerant (-----) C57BL/6
mice. 3 days after the administration of 3 X 10° p-GLO-spl cells or normal cells, mice were
immunized with 20 pg GLq~-Fyr- in M/P (day 0). Their spleens were assayed at various days after
immunization. GL4;~-specific IgM response is depicted as open circles (O) and IgG as solid circles
(0). Each point represents the arithmetic mean of the PFC response of three to five mice t SE. (B)
Kinetics of FyG-specific PFC response in control (-) and tolerant (-----) C57BL/6 mice. Only
IgG PFC responses were assayed.
limpet hemocyanin or horse erythrocytes was not decreased in mice that were given
an i.v. injection of GLO spleen cells, confirming the specificity of the p-GLq~-spl-
induced nonresponsiveness (data not shown) .
Fine Specificity of GL4 Nonresponsiveness.
￿
We have previously demonstrated that the
antibody responses to GLO and GL are highly cross-reactive (7) and that these
antibodies share idiotypic determinants (11) . Therefore, we tested the fine specificity
ofGLcp nonresponsiveness with the cross-reacting polymer GL. Nonresponsiveness was
induced in C57BL/6 mice with GL.0,-palmitoyl-coupled syngeneic cells. 3 days after
induction, mice were challenged with either G14-FyG or GL-FyG. As shown in Table
11, the GL,0- and GL-specific PFC responses were significantly reduced, while the
FyG-PFC responses were not affected. Thus, the effector mechanism (s) which mediate
this tolerance can not distinguish between the closely related cross-reactive polypep-
tides GL and GLO.CHEUNG, SHERR, HEGHINIAN, BENACERRAF, AND DORF
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TABLE 11
Fine Specificity of GL4 Tolerance
* C57BL/6 mice were given 3 X 107 GL¢ coupled spleen cells, i.v., 3 days before challenge with 20 Wg
GL40-FyG or GL-FyG. Animals were sacrificed 8 days after challenge for PFC assay.
$ Arithmetic mean of PFC response t SE; three to four mice are included in each group.
§ Indicates P < 0.02.
Dose Requirementsfor Induction of Nonresponsiveness.
￿
To establish the optimal dose of
p-GLO-spl cells used for tolerance induction, C57BL/6 mice were injected with 2 X
104 to 3 X 10' p-GL4-spl cells, while control groups received equivalent numbers of
normal spleen cells. 3 days later, the mice were immunized with 20 Itg GLO-FyG in
M/P (day 0) and their spleens were assayed on day 8. The degree of tolerance in the
experimental mice was expressed as percent reduction of the control PFC response. As
shown in Fig. 2, there was a dose dependence for tolerance induction by p-GI.4-spl.
At least 2 X 105 cells were required for optimal reduction of both IgM and IgG
responses. Trace labeling studies revealed that -2 ng GLO was carried on 2 X 105 p-
GL(to-spl cells.
Kinetics of Tolerance Induction.
￿
The time required for the development of nonrespon-
siveness and the tolerant state was next investigated. C57BL/6 mice were treated with
3 X 107 p-GLO-spl cells i.v., while control groups were given 3 X 107 normal spleen
cells. As shown in Fig. 3, groups of mice were immunized with 20 Ftg GLO-FyG in
M/P at various times after receiving control or GL.~-coupled spleen cells, and their
spleens were assayed 8 days later. Under optimal conditions G14-specific IgM and
IgG responses were decreased by 80-90% of control responses. The induction of
nonresponsiveness required a latent period (1-2 days before challenge) and the state
of tolerance lasted for at least 63 days after injection.
p-GLO-spl Cells Induce GL4-Specific Suppressor Cells.
￿
Since these antigen modified
cells induced such a strong state of nonresponsiveness lasting at least 2 mo, an active
suppressor mechanism was considered to be involved. Two transfer experiments were
performed in which similar results were obtained in each experiment. Donor animals
were sacrificed 5 days after tolerance induction with p-GLO-spl and their spleen cells
were transferred into normal syngeneic recipients. Control mice received an equal
number of normal spleen cells. All mice were immediately challenged with 20 lig
GL.¢-FyG in M/P and 8 days later their spleens were assayed. 2 X 107 viable spleen
cells from p-GLO-spl-treated donors led to significant (60-70%, P < 0.01) suppression
in the recipient animals (Table III) . The treatment of such suppressor spleen cells
with anti-Thy 1 .2 serum plus complement (C) but not with normal mouse serum
(NMS) plus C before transfer removed the suppressive activity (Table III) . Thus, the
suppression of GLO responses is a T-cell-dependent process.
Induction is Cyclophosphamide Sensitive.
￿
Since suppressor T cells have been shown to
Specific PFC/spleen f SE$
Pretreatment* Challenge
GL¢ or GL
IgM
GL4 or GL
IgG
FyG
IgG
Control cells GL0-FyG 14,000 t 5,630 6,450 t 3,007 14.437 t 4,732
GL¢-spl GL¢-FyG 2,512 t 1,239§ 1,312 t 1,214§ 15,975 t 2,667
Control cells GL-FyG 12,727 t 4,335 9,437 f 3,559 13,050 t 8,395
G14-spl GL-FyG 4,387 t 1,144§ 1,987 f 1,245§ 11,287 ± 4,421\544 SUPPRESSION BY G14-MODIFIED SYNGENEIC CELLS
l
￿
Dose requirement for tolerance induction in C57BL/6 mice. Groups of mice (four to six
mice/group) were injected b*"i'hrxIo^mxx/o'p-Ga4-spcells while control groups received
laomumuers of normal spleen cells. s days later they were challenged with 20 pg GL40-r-yG in
0) and their spleens were assayed for ol(~-speciu
￿
PFC response on day 8. Results are
expressed as percent suppression of the control group responses, Control IgM and IgG responses
averaged 10,000-20,000 PFC/spleen. Each point represents the arithmetic mean of percent sup-
pression ofcontrol PFC responses ± SE. Open circles (0) denote percent suppression ofIgM while
solid circles (0) represent that of IgG PFC response.
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￿
Kinetics of tolerance induction in co7BC/6 mice, Mice
￿
with were injected
￿
xY
G14ti-spl cells or control spleen cells and at various times (day 0 to day 63) afterward challenged
with 20 jAg GLO-FyG in M/P (day 0). 8 days later their spleens were assayed for GLO-specific IgM
or IgG PFC responses, Each point (four-eight mice/group) represents the arithmetic mean of the
percent suppression of the control group response ± SE. Control IgM and IgG responses averaged
10,000-20,000 PFC/spleen. Open circles (0) represent the percent suppression of IgM and solid
circles (0) that of IgG PFC responses.
hosphamide sensitive in other systems (l2, 13) we have analyzed the
phamide sensitivity of the GLO-specific
￿
<57BL/8mice were
rocsaline Lp 2 days before suppression induction
cells. Control mice were given cyclophosphamide 'xsaline 2
days before in injection of 3X \07 normal spleen cells. These nice were then
challenged with 2OAg G1.0-F}G in M/P and their spleens were assayed on day 8. As
shown iuTable IV' suppression could ont 6cdemonstrated iot6e cycop6nop6aooide-
po,treutodgronpgi~eap'C;l^O-spiI6uo,t6ngeomrabooofuouremponxiveneaoiut6in
system is vnoikive tusmall doses of cyclop6oop6arui6m.CHEUNG, SHERR, HEGHINIAN, BENACERRAF, AND DORF
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' 5 days after suppressor cell induction, 2 X 107 spleen cells from tolerant or control groups were transferred
into normal recipients. Tolerant cells were also treated with either NMS plus C or anti-Thy 1.2 serum
plus C before transfer into normal recipients. All mice were then challenged with 20 pg GL~-FyG in
M/P. Spleen cells were assayed 8 days later for PFC.
$ Arithmetic mean PFC response t SE.
§ Indicates P < 0.01.
TABLE III
T-Cell Dependency ofGL¢-Specific Suppression
TABLE IV
GLgi Suppression Is Cyclophosphamide Sensitive
' Mice were treated with 5 mg/kg cytoxan in 0.5 ml saline i.p. 2 days later, suppression was induced with
3 X 107 p-GL0 spleen cells. Control cytoxan group was induced with 3 X 107 normal spleen cells. 3 days
after induction mice were immunized with 20 pg GLO-FyG in M/P (day 0). Their spleens were assayed
8 days later.
$ Arithmetic mean PFC/spleen t SE.
§ Indicates P < 0.01 .
Discussion
The present experiments demonstrate the striking efficiency of cell surface-associ-
ated GLO in inducing a long-lasting state of nonresponsiveness. The intravenous
administration of 2 X 106 to 3 X 107 p-GLO-spl cells carrying 1-100 ng inhibits the
primary GLO-specific IgM and IgG PFC responses. This state of nonresponsiveness
lasts at least 63 days. Although the response to the closely related, serologically cross-
reactive polymer GL is also inhibited, the nonresponsiveness is antigen specific,
because the PFC response to the FyG carrier is not affected. Suppressor cells appear
to be responsible for initiating and (or) maintaining this state of tolerance, because
spleen cells from tolerant mice can transfer tolerance to normal recipients. Moreover,
the induction of nonresponsiveness is cyclophosphamide sensitive and the cells which
can transfer suppression are Thy 1 .2 positive.
The phenomenon we have described contrasts with the state of "low zone" tolerance
described by Dresser and Mitchison (14) and Rajewsky and Brenig (15) . The induction
of low zone tolerance required repeated injection ofsubimmunogeneic concentrations
of antigen over a prolonged period of time. In contrast, GLO-specific tolerance was
rapidly induced (<3 days) after a single intravenous administration of tolerogen.
Cells transferred*
Number
of mice
GLO-specific
IgM
PFC/spleen t SE$
IgG
Control cells 3 10,333 t 328 12,466 t 754
GLO-tolerant cells 4 3,575 t 620§ 4,635 t 1,421§
GLO-tolerant NMS + C treated 5 3,920 t 1,232§ 3,980 t 1,415§
GL4~-tolerant anti-Thy 1 .2 + C 5 9,300 t 3,134 8,980 t 2,199
Pretreatment* GLO-specific PFC/spleen t SE$
D-5 D-3
Number
of mice
GLO
IgM
specific
IgG
Saline Control 4 9,750 t 935 9,226 t 1,029
Saline p-GLO-spl 4 1,800 t 367§ 1,475 t 315§
Cyclophosphamide Control 3 10,933 t 2,140 13,800 t 4,539
Cyclophosphamide p-GL~spl 4 10,000 t 867 9,550 t 1,2701546
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Furthermore, in the present studies, nanogram quantities of soluble p-GLO failed to
induce suppression unless the p-GLO was associated with cells.
The adoptive transfer experiments clearly demonstrated that Thy 1 .2-positive cells
from tolerant mice were required to specifically suppress the GLO antibody response
in normal recipients. Antigen carryover cannot account for the ability to adoptively
transfer suppression, because p-GLO-spl cellsadministered on the day of immunization
with GL0-FyG could not decrease the day 8 GL4 PFC response. In addition,
cyclophosphamide treatment, which has been shown to interfere with the process of
suppressor cell induction (12, 13), abrogates the induction of GL(O tolerance. Thus,
from these various experiments it appears that suppressor T cells are required for the
generation of G14-specific nonresponsiveness induced with p-GLO-spl cells.
It is well established that haptenated syngeneic cells can be used to specifically
suppress a hapten-specific PFC response (3, 4) or contact sensitivity reaction (1, 2) .
The most commonly used haptens for these studies have been trinitrophenyl and
dinitrophenyl. The induction of hapten-specific T-cell tolerance by the i.v. adminis-
tration of nitrophenylated syngeneic cells is at least in part mediated by Thy 1-
positive suppressor cells (4-6) . Furthermore, the induction of trinitrophenyl-specific
suppressor T cells was demonstrated to be cyclophosphamide sensitive (16) . The
results presented in this report closely parallel those noted in the hapten systems, in
that small numbers of antigen-coupled cells are sufficient to induce a potent, long-
lasting T-cell-dependent suppression . However, unlike the chemical conjugation
methods that covalently couple hapten to cell surface proteins, the palmitoyl coupling
method does not covalently associate GL4 with any cell surface molecules. We believe
that the palmitoyl-derivatized peptides are anchored into the lipid portion of the
membrane and may be presented to the immune system in the same form as a foreign
minor histocompatibility determinant. The palmitoyl coupling method should prove
generally applicable to other lysine-containing peptides and proteins. Indeed, initial
experiments have indicated that proteins can be coupled to syngeneic cells to induce
specific suppression .
The route of administration of antigen-modified syngeneic cells may be crucial in
the induction of suppression . In other systems, the i.v. administration of modified
syngeneic cells appears to be the most efficient route for the induction of suppressor
cells (1-3, 17). Experiments are in progress to define (a) the importance of the route
of antigen administration, (b) the cell type(s) that are most efficient in the induction
of suppression, and (c) the nature of the cell surface molecules that provide the
induction signals.
C57BL/6 mice are genetic nonresponders to GLcp by virtue of the fact that they
lack an H-linked Ir gene which is required for GLO responsiveness (7) . The genetic
defect in GLO nonresponder mice appears to function at the level of the induction of
GLO-specific helper T cells. Thus, C57BL/6 nonresponder mice produce anti-GLO
antibody, after immunization with GLO that has been conjugated to an immunogenic
carrier, such as FyG (10), indicating that nonresponder mice do not have a defect in
their B-cell repertoire. Hence, the GLO polypeptide may function as a "hapten" in
C57BL/6 nonresponder mice, and as a result the many similarities between the
suppression induced with antigen-modified cells in the hapten and GL¢, systems may
not be coincidental.
The mechanism(s) of GLO-specific suppression are under investigation. SeveralCHEUNG, SHERR, HEGHINIAN, BENACERRAF, AND DORF
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possible mechanisms can be considered at this time. First, the GL.O suppressor cells
may act directly upon GL4t0 or GL helper T cells. In opposition to this possibility are
the data from various systems, which indicate C57BL/6 nonresponder mice do not
produce helper cells to these polypeptides (18, 19) . A second possibility, which has
been suggested previously (3) and which may apply here, is that the GL0 suppressor
cells act directly on the GI-0- or GL-specific PFC precursor cells. This mechanism
could also explain the lack of fine specificity with respect to GL4 and GL, since Kipps
et al. (11) have demonstrated that the anti-GL¢ and anti-GL responses of C57BL
mice share idiotypic determinants. Finally, an unprecedented mechanism may be
invoked whereby the G14-specific suppressor cells may inactivate a subpopulation of
FyG-specific helper T cells, which preferentially cooperate with GL40- or GL-specific
B cells. Ward et al. (20) have presented evidence supporting the existence of hapten-
restricted T-cell clones. One expectation from such a model would be suppression of
the FyG-specific PFC responses. The failure to demonstrate linked FyG tolerance in
the present experiments may be attributed to the presence of unconjugated FyG
molecules in the GL.q~-FyG and GL-FyG preparations, which could activate FyG-
specific PFC responses independently of GL.p responses.
This report represents the first indication that GL4 nonresponder mice possess
functional T cells with specificity for GLO, and suggests that GL¢ nonresponder
animals can generate a T-cell receptor with specificity for this polymer. Heretofore,
the data have suggested that nonresponder mice lacked helper and suppressor T cells
(8, 18, 19) . Transferable T-cell-mediated suppression was not previously demonstrated
in GLO nonresponder mice (9) . The present experiments demonstrate that GL(~-
specific suppressor cells can be induced in at least one nonresponder strain, and
indicate that the intravenous administration of antigen-modified syngeneic cells is a
very potent means of inducing such cells.
Summary
The palmitoyl derivative of the linear polypeptide of poly-(L-GIu-L-Lys-L-Phe)n
(GLO) can be coupled to spleen cells directly. The intravenous administration of 2
X 105-3 X 107 GLO-coupled syngeneic spleen cells induces GLrp-specific suppressor
T cells in C57BL/6 nonresponder mice. The suppression is antigen specific and can
be detected by the inhibition of the primary GL.O plaque-forming cell response to
challenge with GLO-fowl gamma globulin. The number of inducer cells required for
suppression carry less than 0.1 Ftg of antigen. Spleen cells from tolerized mice can
transfer suppression to normal syngeneic recipients. The suppression is cyclophospha-
mide sensitive and the suppressor cells bear the Thy 1 .2 marker. This method of
inducing antigen-specific suppressor cells may be generally applicable to other antigen
systems.
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